These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21324059)

  • 1. Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy.
    Landrø L; Ueland T; Otterdal K; Frøland SS; Aukrust P
    J Thromb Haemost; 2011 May; 9(5):1075-7. PubMed ID: 21324059
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk.
    Leite KME; Santos Júnior GG; Godoi ETAM; Vasconcelos AF; Lorena VMB; Araújo PSR; Lima KO; Lacerda HR
    Arq Bras Cardiol; 2020 Jan; 114(1):90-97. PubMed ID: 31664319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly active antiretroviral therapy alters inflammation linked to platelet cytokines in HIV-1-infected patients.
    Damien P; Cognasse F; Lucht F; Suy F; Pozzetto B; Garraud O; Hamzeh-Cognasse H
    J Infect Dis; 2013 Sep; 208(5):868-70. PubMed ID: 23757340
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz HAART regimen.
    Chini M; Tsoupras AB; Mangafas N; Tsogas N; Papakonstantinou VD; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
    Int J Immunopathol Pharmacol; 2012; 25(1):247-58. PubMed ID: 22507337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.
    Gresele P; Falcinelli E; Momi S; Francisci D; Baldelli F
    Rev Cardiovasc Med; 2014; 15 Suppl 1():S9-20. PubMed ID: 24987863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial and platelet function alterations in HIV-infected patients.
    Gresele P; Falcinelli E; Sebastiano M; Baldelli F
    Thromb Res; 2012 Mar; 129(3):301-8. PubMed ID: 22192157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapy.
    Corrales-Medina VF; Simkins J; Chirinos JA; Serpa JA; Horstman LL; Jy W; Ahn YS
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):217-8. PubMed ID: 20505474
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.
    Peters L; Neuhaus J; Duprez D; Neaton JD; Tracy R; Klein MB; Mocroft A; Rockstroh J; Dore G; Lundgren JD;
    J Clin Virol; 2014 Jul; 60(3):295-300. PubMed ID: 24793968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth arrest-specific 6 protein in HIV-infected patients: Determination of plasma level and different antiretroviral regimens.
    Lin TY; Lin FH; Hung CC; Liu CL; Hsiao YC; Lee CH; Wang NC
    J Microbiol Immunol Infect; 2021 Oct; 54(5):926-933. PubMed ID: 34210628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting thrombogenicity and inflammation in chronic HIV infection.
    O'Brien MP; Zafar MU; Rodriguez JC; Okoroafor I; Heyison A; Cavanagh K; Rodriguez-Caprio G; Weinberg A; Escolar G; Aberg JA; Badimon JJ
    Sci Adv; 2019 Jun; 5(6):eaav5463. PubMed ID: 31206016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between atazanavir plasma levels and renal function in HIV-positive individuals on antiretroviral therapy with undetectable viral load.
    Luz AJ; Poeta J; Linden R; Antunes MV; Caminha LI; Callegari-Jacques SM; Sprinz E
    Int J Antimicrob Agents; 2013 May; 41(5):497-8. PubMed ID: 23453620
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy.
    Aukrust P; Bjørnsen S; Lunden B; Otterdal K; Ng EC; Ameln W; Ueland T; Müller F; Solum NO; Brosstad F; Frøland SS
    Thromb Haemost; 2000 Aug; 84(2):183-7. PubMed ID: 10959687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy.
    Premeaux TA; Javandel S; Hosaka KRJ; Greene M; Therrien N; Allen IE; Corley MJ; Valcour VG; Ndhlovu LC
    Front Immunol; 2020; 11():1321. PubMed ID: 32695109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
    Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
    AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
    Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
    AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Mondy KE; Gottdiener J; Overton ET; Henry K; Bush T; Conley L; Hammer J; Carpenter CC; Kojic E; Patel P; Brooks JT;
    Clin Infect Dis; 2011 Feb; 52(3):378-86. PubMed ID: 21217185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.
    Shete A; Dhayarkar S; Dhamanage A; Kulkarni S; Ghate M; Sangle S; Medhe U; Verma V; Rajan S; Hattori T; Gangakhedkar R
    AIDS Res Ther; 2020 Jul; 17(1):43. PubMed ID: 32678033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risks in Asian HIV-infected patients receiving boosted-protease inhibitor-based antiretroviral treatment.
    Ounjaijean S; Kulprachakarn K; Aurpibul L; Kaewpoowat Q; Boonyapranai K; Chaiwarith R; Arwon S; Supparatpinyo K; Rerkasem K
    J Infect Dev Ctries; 2021 Mar; 15(2):289-296. PubMed ID: 33690213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.